Literature DB >> 23689123

Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin.

Luke H Hoeppner1, Steven Bach2, Guangqi E1, Ying Cao1, Yan Guo2, Enfeng Wang1, Jianmin Wu3, Mark J Cowley3, David K Chang3,4,5, Nicola Waddell6, Sean M Grimmond6, Andrew V Biankin3,4,5, Roger J Daly3, Xiaohui Zhang2, Debabrata Mukhopadhyay1.   

Abstract

Metastasis, the leading cause of cancer death, requires tumor cell intravasation, migration through the bloodstream, arrest within capillaries, and extravasation to invade distant tissues. Few mechanistic details have been reported thus far regarding the extravasation process or re-entry of circulating tumor cells at metastatic sites. Here, we show that neuropilin-2 (NRP-2), a multifunctional nonkinase receptor for semaphorins, vascular endothelial growth factor (VEGF), and other growth factors, expressed on cancer cells interacts with α5 integrin on endothelial cells to mediate vascular extravasation and metastasis in zebrafish and murine xenograft models of clear cell renal cell carcinoma (RCC) and pancreatic adenocarcinoma. In tissue from patients with RCC, NRP-2 expression is positively correlated with tumor grade and is highest in metastatic tumors. In a prospectively acquired cohort of patients with pancreatic cancer, high NRP-2 expression cosegregated with poor prognosis. Through biochemical approaches as well as Atomic Force Microscopy (AFM), we describe a unique mechanism through which NRP-2 expressed on cancer cells interacts with α5 integrin on endothelial cells to mediate vascular adhesion and extravasation. Taken together, our studies reveal a clinically significant role of NRP-2 in cancer cell extravasation and promotion of metastasis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689123      PMCID: PMC3774599          DOI: 10.1158/0008-5472.CAN-13-0529

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

2.  Quantifying cellular adhesion to extracellular matrix components by single-cell force spectroscopy.

Authors:  Jens Friedrichs; Jonne Helenius; Daniel J Muller
Journal:  Nat Protoc       Date:  2010-07-01       Impact factor: 13.491

3.  Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.

Authors:  Hironao Yasuoka; Rieko Kodama; Mitsuyoshi Hirokawa; Yuuki Takamura; Akira Miyauchi; Michiya Inagaki; Tokio Sanke; Yasushi Nakamura
Journal:  J Clin Endocrinol Metab       Date:  2011-08-31       Impact factor: 5.958

Review 4.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

5.  Neuropilin-2 expression in cancer.

Authors:  Adrian M Jubb; Susan M Sa; Navneet Ratti; Laura A Strickland; Maike Schmidt; Christopher A Callahan; Hartmut Koeppen
Journal:  Histopathology       Date:  2012-03-02       Impact factor: 5.087

6.  Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells?

Authors:  R Tordjman; N Ortéga; L Coulombel; J Plouët; P H Roméo; V Lemarchandel
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

7.  Neuropilin-2: a novel biomarker for malignant melanoma?

Authors:  Erica C Rushing; Megan J Stine; Sarah J Hahn; Sofia Shea; Mark S Eller; Alaa Naif; Sarika Khanna; William H Westra; Achim A Jungbluth; Klaus J Busam; Meera Mahalingam; Rhoda M Alani
Journal:  Hum Pathol       Date:  2011-08-15       Impact factor: 3.466

8.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

9.  A requirement for neuropilin-1 in embryonic vessel formation.

Authors:  T Kawasaki; T Kitsukawa; Y Bekku; Y Matsuda; M Sanbo; T Yagi; H Fujisawa
Journal:  Development       Date:  1999-11       Impact factor: 6.868

10.  A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data.

Authors:  Nuno L Barbosa-Morais; Mark J Dunning; Shamith A Samarajiwa; Jeremy F J Darot; Matthew E Ritchie; Andy G Lynch; Simon Tavaré
Journal:  Nucleic Acids Res       Date:  2009-11-18       Impact factor: 16.971

View more
  43 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.

Authors:  Sandy Giuliano; Yann Cormerais; Maeva Dufies; Renaud Grépin; Pascal Colosetti; Amine Belaid; Julien Parola; Anthony Martin; Sandra Lacas-Gervais; Nathalie M Mazure; Rachid Benhida; Patrick Auberger; Baharia Mograbi; Gilles Pagès
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

3.  Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.

Authors:  Aleksandar Boro; Matthias Je Arlt; Harald Lengnick; Bernhard Robl; Maren Husmann; Josefine Bertz; Walter Born; Bruno Fuchs
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

4.  Quantification of cancer cell extravasation in vivo.

Authors:  Yohan Kim; Karla C Williams; Carson T Gavin; Emily Jardine; Ann F Chambers; Hon S Leong
Journal:  Nat Protoc       Date:  2016-04-21       Impact factor: 13.491

5.  Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.

Authors:  Vinoth Sundar Rajan; Valérie M Laurent; Claude Verdier; Alain Duperray
Journal:  Biophys J       Date:  2017-03-28       Impact factor: 4.033

6.  P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer.

Authors:  Hira Lal Goel; Bryan Pursell; Leonard D Shultz; Dale L Greiner; Rolf A Brekken; Craig W Vander Kooi; Arthur M Mercurio
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

Review 7.  Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.

Authors:  Anitha K Shenoy; Jianrong Lu
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

Review 8.  Control of cellular motility by neuropilin-mediated physical interactions.

Authors:  Xiaobo Li; Matthew W Parker; Craig W Vander Kooi
Journal:  Biomol Concepts       Date:  2014-05

9.  A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis.

Authors:  Philip T Pauerstein; Krissie Tellez; Kirk B Willmarth; Keon Min Park; Brian Hsueh; H Efsun Arda; Xueying Gu; Haig Aghajanian; Karl Deisseroth; Jonathan A Epstein; Seung K Kim
Journal:  Development       Date:  2017-09-11       Impact factor: 6.868

10.  BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models.

Authors:  Arsheed A Ganaie; Firdous H Beigh; Matteo Astone; Marina G Ferrari; Raihana Maqbool; Syed Umbreen; Aijaz S Parray; Hifzur R Siddique; Tabish Hussain; Paari Murugan; Colm Morrissey; Shahriar Koochekpour; Yibin Deng; Badrinath R Konety; Luke H Hoeppner; Mohammad Saleem
Journal:  Clin Cancer Res       Date:  2018-08-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.